4//SEC Filing
Hansen Carl L. G. 4
Accession 0001209191-23-012199
CIK 0001703057other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:33 PM ET
Size
7.9 KB
Accession
0001209191-23-012199
Insider Transaction Report
Form 4
Hansen Carl L. G.
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Common Shares
2023-02-22$2.70/sh+56,125$151,538→ 505,125 total - Exercise/Conversion
Share option (right to buy)
2023-02-22−56,125→ 6,557,566 totalExercise: $2.70Exp: 2030-11-18→ Common Shares (56,125 underlying)
Holdings
- 55,859,493(indirect: See footnote)
Common Shares
Footnotes (2)
- [F1]These shares are held by Thermopylae Holdings Ltd., which is an entity wholly owned by the reporting person.
- [F2]The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
AbCellera Biologics Inc.
CIK 0001703057
Entity typeother
Related Parties
1- filerCIK 0001834412
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:33 PM ET
- Size
- 7.9 KB